Guidelines for evaluating the efficacy and safety of live anticoccidial vaccines, and obtaining approval for their use in chickens and turkeys.
These guidelines are intended to aid those engaged in poultry research in the design, implementation and interpretation of laboratory, floor-pen and field studies for the assessment of the efficacy and safety of live anticoccidial vaccines for immunization of chickens and turkeys against Eimeria species. In addition to efficacy and safety requirements, manufacture, quality control and licensing considerations are discussed. The guidelines do not address subunit vaccines comprising non-viable material, but many of the principles described will be relevant to such vaccines if they are developed in the future. Guidelines are available in some countries for avian vaccines of bacterial or viral origin but specific standards for anticoccidial vaccines in poultry have not, as far as we know, been produced. Information is provided on general requirements of registration authorities (based upon regulations applicable in the European Union and the USA) for obtaining marketing authorizations for vaccines. These guidelines may assist poultry specialists in providing specific information for administrators involved in the decision-making process leading to registration of new vaccines, and are intended to facilitate the worldwide adoption of consistent, standard procedures.
Chapman
H D
HD
Department of Poultry Science, University of Arkansas, Fayetteville, AR 72701, USA. dchapman@uark.edu
Roberts
B
B
Shirley
M W
MW
Williams
R B
RB
D000818:Animals; D002645:Chickens; D002986:Clinical Trials as Topic / Q000592:standards / Q000662:veterinary*; D003048:Coccidiosis / Q000517:prevention & control / Q000662:veterinary*; D017277:Drug Approval / Q000379:methods*; D005062:European Union; D011201:Poultry Diseases / Q000517:prevention & control*; D016052:Protozoan Vaccines / Q000009:adverse effects; D014422:Turkeys; D014481:United States
D016052:Protozoan Vaccines